tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment
PremiumCompany AnnouncementsCytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment
1M ago
CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path
Premium
The Fly
CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path
2M ago
CytoDyn to present poster at AACR conference on mTNBC
Premium
The Fly
CytoDyn to present poster at AACR conference on mTNBC
2M ago
CytoDyn Appoints Robert Hoffman as New CFO
PremiumCompany AnnouncementsCytoDyn Appoints Robert Hoffman as New CFO
7M ago
CytoDyn appoints Robert Hoffman as CFO
Premium
The Fly
CytoDyn appoints Robert Hoffman as CFO
7M ago
CytoDyn leadership team to attend ESMO Breast Cancer meeting
Premium
The Fly
CytoDyn leadership team to attend ESMO Breast Cancer meeting
7M ago
CytoDyn appoints Richard Pestell as lead consultant in oncology
PremiumThe FlyCytoDyn appoints Richard Pestell as lead consultant in oncology
1y ago
CytoDyn announces FDA clearance of Phase II oncology trial
Premium
The Fly
CytoDyn announces FDA clearance of Phase II oncology trial
1y ago
CytoDyn appoints Melissa Palmer as lead consultant in hepatology
Premium
The Fly
CytoDyn appoints Melissa Palmer as lead consultant in hepatology
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100